Benjamin Edwards Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24M Buy
26,111
+1,806
+7% +$1.83M 0.24% 118
2025
Q4
$26.1M Buy
24,305
+530
+2% +$507K 0.29% 98
2025
Q3
$18.1M Buy
23,775
+7,803
+49% +$5.81M 0.21% 123
2025
Q2
$12.5M Buy
15,972
+1,072
+7% +$833K 0.16% 146
2025
Q1
$12.3M Sell
14,900
-365
-2% -$304K 0.17% 137
2024
Q4
$11.8M Buy
15,265
+1,802
+13% +$1.49M 0.17% 143
2024
Q3
$11.9M Buy
13,463
+10,231
+317% +$9.2M 0.17% 145
2024
Q2
$2.93M Buy
3,232
+240
+8% +$192K 0.56% 44
2024
Q1
$2.33M Buy
2,992
+486
+19% +$346K 0.46% 57
2023
Q4
$1.46M Sell
2,506
-32
-1% -$18.7K 0.32% 91
2023
Q3
$1.36M Sell
2,538
-382
-13% -$197K 0.32% 95
2023
Q2
$1.37M Buy
2,920
+266
+10% +$112K 0.32% 91
2023
Q1
$912K Buy
2,654
+333
+14% +$112K 0.22% 128
2022
Q4
$849K Sell
2,321
-1,515
-39% -$537K 0.22% 131
2022
Q3
$1.24M Buy
3,836
+28
+0.7% +$8.87K 0.37% 82
2022
Q2
$1.24M Buy
3,808
+914
+32% +$274K 0.36% 85
2022
Q1
$829K Buy
2,894
+318
+12% +$81.8K 0.24% 126
2021
Q4
$712K Buy
2,576
+1,851
+255% +$469K 0.23% 116
2021
Q3
$168K Buy
725
+121
+20% +$29.9K 0.1% 189
2021
Q2
$139K Buy
604
+32
+6% +$6.43K 0.1% 187
2021
Q1
$107K Sell
572
-62
-10% -$12.1K 0.08% 194
2020
Q4
$107K Buy
634
+106
+20% +$15.8K 0.08% 183
2020
Q3
$78K Buy
528
+459
+665% +$71K 0.06% 183
2020
Q2
$11K Hold
69
0.01% 290
2020
Q1
$10K Buy
+69
New +$9.48K 0.01% 285

Other funds holding LLY

Benjamin Edwards Inc's LLY Position: Q1 2026 in Review

Benjamin Edwards Inc increased its Eli Lilly (LLY) stake by 7.4% in Q1 2026, buying an estimated $1.83M and bringing the position to 26,111 shares worth $24M. The position accounts for 0.24% of the portfolio, ranked #118.

Benjamin Edwards Inc first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $26.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Benjamin Edwards Inc held 26,111 shares of Eli Lilly worth $24M as of Q1 2026.
  • Benjamin Edwards Inc bought 1,806 Eli Lilly shares in Q1 2026, an estimated $1.83M.
  • Eli Lilly made up 0.24% of Benjamin Edwards Inc's portfolio in Q1 2026, its #118 holding.
  • Benjamin Edwards Inc first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Benjamin Edwards Inc's Eli Lilly position peaked at $26.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Benjamin Edwards Inc's 13F filing for Q1 2026, filed 12 May 2026.